CRC Screening and Quality of Colonoscopy

This program will include a discussion of investigational agents not approved by the FDA for use in the United States.

CRC: Overview

Development of CRC

Classification of Colorectal Polyps Conventional Adenomas

Characteristics of Conventional Adenomas

Conventional Adenomas

Classification of Colorectal Polyps Serrated Lesions

Classification of Colorectal Polyps Serrated Lesions

Characteristics of Serrated Lesions

Sessile Serrated Polyps

CRC Screening Defined

Approaches to CRC Screening

Approaches to Opportunistic CRC Screening

CRC Screening Tests: Overview

Fecal Immunochemical Test

FIT-Fecal DNA Test (Cologuard®)

Methylated Septin 9 DNA (Epi proColon®)

Colonoscopy

Flexible Sigmoidoscopy

MSTF Ranking of CRC Screening Tests

CRC Screening Recommendations for Average Risk Patients

Screening Recommendations for Patients With Family History of CRC

CRC Screening Role of PCP vs Gastroenterologist

Importance of Operator Skill in Colonoscopy

Adenoma Detection Rate

ADR and Risk of CRC or Death Kaiser Permanente Study

Factors That Impact ADR

Technologies That Can Aid Visualization of Adenomas

Electronic Chromoendoscopy With NBI

Chromoendoscopy With Methylene Blue MMX*

Fold-Flattening Devices

Conclusions

Abbreviations